SCHEMBL14097539

SCHEMBL14097539

CSc1ncc(-c2ccc3[nH]c(NC(=O)NC4CCCC4)nc3c2)cn1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.56
▸ RAB9A P51151 3/20 0.56
▸ MAPK1 P28482 1/20 0.44
▸ PIK3CA P42336 1/20 0.44
▸ PIK3CB P42338 1/20 0.44
▸ TBK1 Q9UHD2 3/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ POLB P06746 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ EPHX1 P07099 3/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ JAK1 P23458 1/20 0.40
▸ JAK3 P52333 1/20 0.40
▸ PDE4B Q07343 1/20 0.39
▸ PDPK1 O15530 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAP4K4 O95819 1/20 0.38
▸ ABL1 P00519 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14097538 0.84 ABL1 (0.40) NPC1RAB9ATBK1SMN1; SMN2POLB
SCHEMBL14097487 0.82 ABL1 (0.57) ABL1
SCHEMBL14097552 0.80 NPC1 (0.61) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL14097432 0.77 ABL1 (0.52) ABL1
SCHEMBL14097410 0.76 ABL1 (0.59) NPC1RAB9APOLBABL1
SCHEMBL544177 0.73 NPC1 (0.62) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL9394577 0.73 NPC1 (1.00) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL14097416 0.72 ABL1 (0.53) ABL1
SCHEMBL14097444 0.69 ABL1 (0.54) ABL1
SCHEMBL14097429 0.69 ABL1 (0.59) ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
EP-1341769-B1 BACTERIAL GYRASE INHIBITORS AND USES THEREOF VERTEX PHARMA (US) 2007-10-17 — — EP disclosed
Send feedback